sugammadex fresenius kabi
fresenius kabi deutschland gmbh - sugammadex sodium - neuromuskuläre blockade - alle anderen therapeutischen produkte - reversal of neuromuscular blockade induced by rocuronium or vecuronium in adults. for the paediatric population: sugammadex is only recommended for routine reversal of rocuronium induced blockade in children and adolescents aged 2 to 17 years.
sugammadex amomed
aop orphan pharmaceuticals gmbh - sugammadex sodium - neuromuskuläre blockade - alle anderen therapeutischen produkte - umkehrung der neuromuskulären blockade durch rocuronium oder vecuronium. for the paediatric population: sugammadex is only recommended for routine reversal of rocuronium induced blockade in children and adolescents aged 2 to 17 years.
sugammadex piramal
piramal critical care b.v. - sugammadex sodium - neuromuskuläre blockade - sugammadex - reversal of neuromuscular blockade induced by rocuronium or vecuronium in adults.
sugammadex adroiq
extrovis eu ltd. - sugammadex sodium - neuromuskuläre blockade - alle anderen therapeutischen produkte - reversal of neuromuscular blockade induced by rocuronium or vecuronium in adults. for the paediatric population: sugammadex is only recommended for routine reversal of rocuronium induced blockade in children and adolescents aged 2 to 17 years.
lioresal intrathecal 10 mg/5 ml infusionslösung
novartis pharma gmbh (8011799) - baclofen - infusionslösung - teil 1 - infusionslösung; baclofen (05931) 2 milligramm
lioresal intrathecal 10 mg/20 ml infusionslösung
novartis pharma gmbh (8011799) - baclofen - infusionslösung - teil 1 - infusionslösung; baclofen (05931) 0,5 milligramm
fragmin 10'000 i.e./1 ml injektionslösung
pfizer ag - dalteparinum natricum - injektionslösung - dalteparinum natricum 10000 u.i., natrii chloridum, aqua ad iniectabile q.s. ad solutionem pro 1 ml. - anticoagulans - biotechnologika
fragmin 10'000 i.e./4 ml injektionslösung
pfizer ag - dalteparinum natricum - injektionslösung - dalteparinum natricum 2500 u.i., natrii chloridum, aqua ad iniectabile q.s. ad solutionem pro 1 ml. - anticoagulans - biotechnologika
fragmin 2'500 i.e./0.2 ml injektionslösung
pfizer ag - dalteparinum natricum - injektionslösung - dalteparinum natricum 2500 u.i., natrii chloridum, aqua ad iniectabile q.s. ad solutionem pro 0.2 ml. - anticoagulans - biotechnologika
fragmin 5'000 i.e./0.2 ml injektionslösung
pfizer ag - dalteparinum natricum - injektionslösung - dalteparinum natricum 5000 u.i., aqua ad iniectabile q.s. ad solutionem pro 0.2 ml. - anticoagulans - biotechnologika